Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Diabetes -

Diabetes

N. Schaper, C.D.A. Stehouwer (Herausgeber)

Buch | Hardcover
256 Seiten
2009
Clinical Publishing,an imprint of Atlas Medical Publishing Ltd (Verlag)
978-1-904392-87-3 (ISBN)
CHF 87,25 inkl. MwSt
Reviews the various agents used to manage blood sugar, and the mechanisms by which their therapeutic effect is achieved: stimulating increased secretion of insulin, decreasing insulin resistance, interference with glucose production in the liver and suppression of appetite.
The increasing incidence of type II diabetes, often in association with cardiovascular disease, constitutes one of the major healthcare challenges of the 21st century. However, physicians can now deploy a wide range of therapeutic agents, singly and in combination, to help lower and stabilise blood sugar levels. Drawing on the expertise of internationally-recognised authorities in their fields, this new volume describes the modes of action of each of these types of treatment and evaluates their effectiveness.In the first section of the book, the authors review the various agents used to manage blood sugar, and the mechanisms by which their therapeutic effect is achieved: stimulating increased secretion of insulin, decreasing insulin resistance, interference with glucose production in the liver and suppression of appetite. The second section of the book deals with the treatment of associated cardiovascular problems in the diabetic patient, including antihypertensive, lipid-lowering, and anti-platelet therapies, as well as the management of other complications associated with diabetes, including polyneuropathy."
Therapeutic Strategies in Diabetes" reviews the evidence for all of these new treatments, evaluates the potential for new and emerging therapies, and presents an informed view of current recommendations for best-practice management.

PART I: Metabolic Considerations; 1. Glucose Lowering Therapy, M Evans, R Peter; 2. Insulin analogues, G Bolli; 3. New developments in insulin administration, E Renard; 4. C-peptide, J Wahren, K Ekberg, H Jornvall; 5. Metformin - new uses for an old drug, A Vaag, S Lund; 6. Thiazolidinediones, AJ Gilde, B Staels; 7. Rimonabant: CB-1 blockade and possibilities for glucose and glucose tolerance improvement, L Van Gaal; 8. Incretin hormones & diabetes mellitus, T Vilsboll, FK Knop, CF Deacon, JJ Holst; PART II: Cardiovascular considerations; 9. An overview of current lipid-lowering treatments, JPD Reckless; 10. Statins, niacin and fibrate therapy, M Fisher, F Vissereren; 11. CETP-inhibitors, R Dullaart; 12. Antihypertensive treatment: overview, J McKnight, P Padfield, M Strachan; 13. CE-inhibitors and angiotensin receptor blockers, J Segura, L Ruilope; 14. Antiplatelet therapy in diabetes, JA Colwell; 15. Folic acid complications, C van Guldener, YM Smulders; 16. Treatment of symptomatic diabetic polyneuropathy, AJ Boulton, E Salgami; Abbreviations; General Index.

Erscheint lt. Verlag 30.9.2009
Reihe/Serie Therapeutic Strategies in ...
Zusatzinfo charts, diagrams, halftones, tables
Verlagsort Oxford
Sprache englisch
Maße 170 x 240 mm
Themenwelt Medizinische Fachgebiete Innere Medizin Diabetologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
ISBN-10 1-904392-87-3 / 1904392873
ISBN-13 978-1-904392-87-3 / 9781904392873
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Norbert Suttorp; Martin Möckel; Britta Siegmund …

Buch | Softcover (2017)
ABW Wissenschaftsverlagsgesellschaft
CHF 79,95